Inactive Instrument

Other languages VentriPoint Diagnostics Ltd. Toronto S.E.

Equities

VPT

CA92281P2008

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ventripoint Diagnostics Ltd. Appoints Matt Dobson as Marketing Director	06-13
Ventripoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-31
Ventripoint Diagnostics Ltd. Submits Next Generation of Software, VMS+4.0, to the U.S. Food and Drug Administration	05-06
Duke University Health Center Purchases Ventripoint's AI Heart-Scan Technology	05-01
Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30
Ventripoint Diagnostics Ltd. Releases Significant Upgrade to the Design and Function of Its Whole-Heart Analysis System (VMS+3.2)	03-04
Ventripoint Diagnostics Ltd. Showcases A.I. Powered Heart-Scanning Technology at International Cardiology Conferences	02-20
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as Interim CEO	02-05
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as President	02-05
The Paediatric Heart Centre At the Medical University of Vienna Has Chosen to Adopt the Vms+ as Its Cardiac Diagnostic Tool	02-01
VentriPoint Diagnostics Ltd. Announces Appointment of Dr. Luc Mertens to Clinical Advisory Board	01-20
VentriPoint Diagnostics Ltd. Enters into A Global Distribution and Marketing Agreement with Ascend Cardiovascular	12-12
VentriPoint Diagnostics Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29
VentriPoint Diagnostics Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23
Ventripoint Welcomes Evelina London Children's Hospital as Newest Vms+ User	22/08/23
Ventripoint Diagnostics Ltd. Announces That Ventripoint and Ascend Cardiovascular, Llc Have Developed A New Integrated Product	18/08/23
Ventripoint Diagnostics Ltd. Announces Collaboration with Ascend Cardiovascular	10/08/23
VentriPoint Diagnostics Ltd. Announces Purchase of VMS+ by Medical Center University of Freiburg	18/07/23
VentriPoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	31/05/23
VentriPoint Diagnostics Ltd. Auditor Raises 'Going Concern' Doubt	30/04/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages VentriPoint Diagnostics Ltd. Toronto S.E.

Equities

VPT

CA92281P2008

Other languages

Filters